{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-310315","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2026-07-21T20:10:17+00:00","discovered_at":"2026-07-21T20:11:01.384903+00:00","generated_at":"2026-07-21T20:11:07.129386+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Rein Therapeutics stockholders approve increase in authorized shares to 200M, re-elect directors","bullets":["Elected Josef H. von Rickenbach and Reinhard J. Ambros as Class III directors.","Approved amendment to increase authorized common shares from 100M to 200M (61.0M for, 2.4M against).","Ratified CBIZ CPAs P.C. as independent auditor for FY2026 (62.95M for, 0.17M against).","Advisory say-on-pay approved with 37.6M for, 0.9M against, 25.1M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-310315","json":"https://secwatch.observer/filing/0001193125-26-310315.json","markdown":"https://secwatch.observer/filing/0001193125-26-310315.md","text":"https://secwatch.observer/filing/0001193125-26-310315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/0001193125-26-310315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/d89210d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-21T20:11:07.129386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}